JB Chemicals & Pharmaceuticals Limited has submitted the Exchange a copy Srutinizers report of Annual General Meeting held on August 06, 2025. Further, the company has informed the Exchange regarding voting results.
JBCHEPHARM · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
JB Chemicals held its 49th AGM on August 6, 2025 via video conferencing, where all 14 resolutions were passed with the required majority. Shareholders approved the audited financial statements for FY25, confirmed an interim dividend of Rs. 8.50 per share, and declared a final dividend of Rs. 7.00 per share (total FY25 dividend of Rs. 15.50 per share on a Rs. 1 face value). Re-appointments of statutory auditor Deloitte Haskins & Sells LLP and three independent directors (Ashwani Kumar Puri, Sumit Bose, Richa Arora) were approved, along with CEO Nikhil Chopra's revised remuneration and re-appointment. A change in the registered office and waiver of lock-in restrictions on CEO shares under the ESOP scheme also received shareholder approval. About 80.91% of total shares (126.47 crore out of 156.32 crore) participated in the voting through remote e-voting and e-voting at the meeting.
Retail shareholders benefit from a combined FY25 dividend of Rs. 15.50 per share. While all resolutions passed, the re-appointment of director Gaurav Trehan saw notable dissent with 23% of votes against, and auditor/CEO resolutions saw around 10% opposition from institutional investors, which may reflect some governance concerns worth monitoring.